NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42.17 | 196.58 | Sale to Issuer | 4.66 | 33.11k | -0.13% |
| 2026-03-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -2.56k | 11.37k | 売り | 4.44 | 33.11k | -7.18% |
| 2026-03-31 | Mr. Steven MertensCTO | -151.00 | 703.96 | Sale to Issuer | 4.66 | 16.88k | -0.89% |
| 2026-03-31 | Mr. David A. RosaPresident, CEO & Director | -409.67 | 1.91k | Sale to Issuer | 4.66 | 124.73k | -0.33% |
| 2026-03-12 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -152.83 | 733.60 | 売り | 4.80 | 35.71k | -0.43% |
| 2026-03-10 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -2.29k | 10.98k | 売り | 4.80 | 33.64k | -6.37% |
| 2026-03-01 | Mr. David J. WambekeChief Business Officer | 166.67k | 670.40k | 買い | 4.02 | 166.67k | - |
| 2026-02-18 | Mr. Steven MertensCTO | -1.23k | 5.02k | Sale to Issuer | 4.08 | 16.51k | -6.93% |
| 2026-02-18 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -302.00 | 1.23k | Sale to Issuer | 4.08 | 35.92k | -0.83% |
| 2026-02-18 | Mr. David A. RosaPresident, CEO & Director | -11.89k | 48.50k | Sale to Issuer | 4.08 | 124.19k | -8.74% |
| 2025-12-31 | Mr. Steven MertensCTO | -151.00 | 686.75 | Sale to Issuer | 4.55 | 12.98k | -1.15% |
| 2025-12-31 | Mr. David A. RosaPresident, CEO & Director | -409.67 | 1.86k | Sale to Issuer | 4.55 | 107.48k | -0.38% |
| 2025-12-31 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42.17 | 191.77 | Sale to Issuer | 4.55 | 35.04k | -0.12% |
| 2025-09-30 | Mr. Steven MertensCTO | -151.00 | 805.07 | Sale to Issuer | 5.33 | 12.61k | -1.18% |
| 2025-09-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42.17 | 224.82 | Sale to Issuer | 5.33 | 35.08k | -0.12% |
| 2025-09-30 | Mr. David A. RosaPresident, CEO & Director | -409.67 | 2.18k | Sale to Issuer | 5.33 | 107.89k | -0.38% |
| 2025-09-05 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -5.00k | 22.20k | 売り | 4.44 | 34.98k | -12.51% |
| 2025-06-30 | Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison | -42.17 | 171.53 | Sale to Issuer | 4.07 | 39.83k | -0.11% |
| 2025-06-30 | Mr. Steven MertensCTO | -151.00 | 614.27 | Sale to Issuer | 4.07 | 12.24k | -1.22% |
| 2025-06-30 | Mr. David A. RosaPresident, CEO & Director | -409.67 | 1.67k | Sale to Issuer | 4.07 | 106.39k | -0.38% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。